2.Can Suprascapular Venous Engorgement with a Paralabral Cyst in the Shoulder Aid the Diagnosis of Suprascapular Neuropathy?: A Cohort Study of Level of Evidence III
Jinho LEE ; Jin-Young PARK ; Hong-Keun PARK ; Tae-sup KIM
The Korean Journal of Sports Medicine 2023;41(4):201-206
Purpose:
Suprascapular neuropathy can be caused by a solid mass, transverse scapular ligament hypertrophy, paralabral cyst, or dilatation of a suprascapular vein. Studies have measured the size of the cyst and veins using magnetic resonance imaging (MRI) to aid diagnosis of suprascapular neuropathy. However, it is often difficult to determine the size of a cyst and vein. we measured cyst and vein size as potential diagnostic markers for suprascapular neuropathy.
Methods:
This study retrospectively enrolled 118 patients diagnosed with a paralabral cyst in a clinic from January 2016 to December 2019. After excluding other neuropathies and cysts not related to the course of the suprascapular nerve, a total of 67 patients were analyzed. The cyst diameter, cyst volume, and vein diameter were measured engorgement by MRI in axial, coronal, and sagittal T2-weighted images. Cutoff values were established based on Youden’s index.
Results:
There was no significant difference between the neuropathy and control groups in cyst coronal diameter, but the neuropathy group had greater sagittal (p=0.001), axial (p=0.001), and maximum cyst diameters (p=0.005), cyst volume (p=0.003), and coronal (p=0.002), axial (p=0.001), and maximum vein diameters (p=0.001).
Conclusion
In suprascapular neuropathy symptomatic patients, electromyographyerve conduction velocity tests are eventually needed when in doubt. However, measuring cyst diameter, volume, and suprascapular vein diameter as a screening test could be considered.
3.Atraumatic Splenic Hemorrhage as a Rare Complication of Pancreatitis: Case Report and Literature Review
Deepanshu JAIN ; Byeori LEE ; Michael RAJALA
Clinical Endoscopy 2020;53(3):311-320
Splenic hemorrhage (hematoma and rupture) is a rare complication of pancreatitis. In this article, we present a rare case of spontaneous splenic rupture as a complication of acute pancreatitis. A literature review was also completed to describe the patient characteristics, associated pancreatitis etiology, clinical presentations, risk factors, diagnostic and treatment modalities, and outcomes.
4.Dasatinib induces severe hemorrhagic colitis in a patient with accelerated phase of chronic myelogenous leukemia.
Eunjung YIM ; Yeon Geun CHOI ; Yoon Jeong NAM ; Jain LEE ; Jeong A KIM
The Korean Journal of Internal Medicine 2018;33(2):446-448
No abstract available.
Colitis*
;
Dasatinib*
;
Humans
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive*
5.Early Clinical Outcomes of a New Posteriorly Stabilized Total Knee Arthroplasty Prosthesis: Comparisons with Two Established Prostheses
Nimesh P. JAIN ; Sung Yup LEE ; Vivek M. MOREY ; Suri CHONG ; Yeon Gwi KANG ; Tae Kyun KIM
The Journal of Korean Knee Society 2017;29(3):180-188
PURPOSE: We sought to determine whether early clinical performance of new posterior stabilized (PS) knee system, the Vega-PS (Aesculap), is better than that of two established total knee arthroplasty (TKA) prostheses, the E.motion-PS (Aesculap) and the Genesis II (Smith & Nephew) in terms of functional outcomes, patient satisfaction, and incidence of adverse events. MATERIALS AND METHODS: We compared the clinical outcomes of 206 consecutive TKAs using Vega-PS with those of 205 TKAs using E.motion-PS and 216 TKAs using Genesis II at 2 years of follow-up. RESULTS: Overall, the knees with the Vega-PS had better functional outcome scores than the knees with the E.motion-PS, but had similar outcome scores to the knees with the Genesis II, as evident from the American Knee Society knee score (94.2 vs. 92.5 vs. 93.2), Western Ontario McMaster Universities Osteoarthritis (WOMAC) stiffness index (1.8 vs. 2.3 vs. 2.0), WOMAC function index (11.8 vs. 16.8 vs. 18.5), Short Form 36 (SF-36) physical component summary score (41.9 vs. 39.3 vs. 41.6), and SF-36 mental component summary score (50.0 vs. 45.8 vs. 46.9). Patient satisfaction was higher in the Vega-PS and Genesis II groups than the E.motion-PS group. No notable group differences were found in terms of the incidence of adverse events. CONCLUSIONS: The Vega-PS, a newly developed PS fixed bearing prosthesis, had comparable or superior clinical performance in comparison with the two established fixed or mobile bearing PS prostheses.
Arthroplasty
;
Arthroplasty, Replacement, Knee
;
Follow-Up Studies
;
Incidence
;
Knee
;
Ontario
;
Osteoarthritis
;
Patient Satisfaction
;
Prostheses and Implants
;
Prosthesis Design
6.Evaluation and treatment of facial feminization surgery: part II. lips, midface, mandible, chin, and laryngeal prominence
Brian N. DANG ; Allison C. HU ; Anthony A. BERTRAND ; Candace H. CHAN ; Nirbhay S. JAIN ; Miles J. PFAFF ; James C. LEE ; Justine C. LEE
Archives of Plastic Surgery 2022;49(1):5-11
Facial feminization surgery (FFS) refers to a set of procedures aimed at altering the features of a masculine face to achieve a more feminine appearance. In the second part of this twopart series, assessment and operations involving the midface, mandible, and chin, as well as soft tissue modification of the nasolabial complex and chondrolaryngoplasty, are discussed. Finally, we provide a review of the literature on patient-reported outcomes in this population following FFS and suggest a path forward to optimize care for FFS patients.
7.Evaluation and treatment of facial feminization surgery: part I. forehead, orbits, eyebrows, eyes, and nose
Brian N. DANG ; Allison C. HU ; Anthony A. BERTRAND ; Candace H. CHAN ; Nirbhay S. JAIN ; Miles J. PFAFF ; James C. LEE ; Justine C. LEE
Archives of Plastic Surgery 2021;48(5):503-510
Facial feminization surgery (FFS) incorporates aesthetic and craniofacial surgical principles and techniques to feminize masculine facial features and facilitate gender transitioning. A detailed understanding of the defining male and female facial characteristics is essential for success. In this first part of a two-part series, we discuss key aspects of the general preoperative consultation that should be considered when evaluating the prospective facial feminization patient. Assessment of the forehead, orbits, hairline, eyebrows, eyes, and nose and the associated procedures, including scalp advancement, supraorbital rim reduction, setback of the anterior table of the frontal sinus, rhinoplasty, and soft tissue modifications of the upper and midface are discussed. In the second part of this series, bony manipulation of the midface, mandible, and chin, as well as soft tissue modification of the nasolabial complex and chondrolaryngoplasty are discussed. Finally, a review of the literature on patient-reported outcomes in this population following FFS is provided.
8.Evaluation and treatment of facial feminization surgery: part I. forehead, orbits, eyebrows, eyes, and nose
Brian N. DANG ; Allison C. HU ; Anthony A. BERTRAND ; Candace H. CHAN ; Nirbhay S. JAIN ; Miles J. PFAFF ; James C. LEE ; Justine C. LEE
Archives of Plastic Surgery 2021;48(5):503-510
Facial feminization surgery (FFS) incorporates aesthetic and craniofacial surgical principles and techniques to feminize masculine facial features and facilitate gender transitioning. A detailed understanding of the defining male and female facial characteristics is essential for success. In this first part of a two-part series, we discuss key aspects of the general preoperative consultation that should be considered when evaluating the prospective facial feminization patient. Assessment of the forehead, orbits, hairline, eyebrows, eyes, and nose and the associated procedures, including scalp advancement, supraorbital rim reduction, setback of the anterior table of the frontal sinus, rhinoplasty, and soft tissue modifications of the upper and midface are discussed. In the second part of this series, bony manipulation of the midface, mandible, and chin, as well as soft tissue modification of the nasolabial complex and chondrolaryngoplasty are discussed. Finally, a review of the literature on patient-reported outcomes in this population following FFS is provided.
9.Synchronous diffuse large B-cell lymphoma of the small intestine and adenocarcinoma of the colon.
Ji Hyun YANG ; Jain LEE ; Shin Bum KIM ; Seon Hoo KIM ; Guk Jin LEE
The Korean Journal of Internal Medicine 2018;33(2):438-441
No abstract available.
Adenocarcinoma*
;
B-Lymphocytes*
;
Colon*
;
Gastrointestinal Neoplasms
;
Intestine, Small*
;
Lymphoma
;
Lymphoma, B-Cell*
10.A Case of Photodynamic Therapy after Endoscopic Submucosal Dissection for the Treatment of Early Gastric Cancer that Mimicked Submucosal Tumor.
Woo Seok CHOI ; Jong Jae PARK ; Bum Jae LEE ; Jain PARK ; Sung Ho KIM ; Eunhye LIM ; Jae Seon KIM ; Young Tae BAK
Korean Journal of Gastrointestinal Endoscopy 2008;37(6):424-428
Several cases of photodynamic therapy (PDT) for the curative treatment of early gastric cancer have recently been reported. However, PDT has been performed in only limited cases because it is impossible to determine the pathologic subtype or stage of the malignant lesion after the procedure. Nevertheless, PDT combined with endoscopic submucosal dissection (ESD) is expected to enhance the accuracy of the pathologic assessment and enable more effective, safe treatment for early gastric cancer. Furthermore, PDT may exert a complementary and synergetic effect on ESD for the atypical forms of early gastric cancer. From this background, we report here on a case of early gastric cancer that mimicked submucosal tumor, and this was removed by ESD, and then this was followed by adjuvant PDT. The patient had a high risk for operation due to his old age and comorbidity. After the procedure, he achieved complete remission and he is currently under follow up: he is without recurrence of tumor one year after ESD.
Comorbidity
;
Humans
;
Photochemotherapy
;
Recurrence
;
Stomach Neoplasms
;
Triazenes